Skip to main content

Want a detailed portfolio tracker?

Aardvark Therapeutics (AARD) P/E (2025 - 2026)

Aardvark Therapeutics (AARD) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Aardvark Therapeutics (AARD) P/E is -1.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aardvark Therapeutics (AARD)

YearP/EChange
2026-1.89-61.76%
2025-4.95N/A

Comparison Aardvark Therapeutics (AARD) P/E with competitors

Aardvark Therapeutics (AARD) P/E is -1.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.23%
ENLVEnlivex Ltd0.07-103.95%
FGENFibroGen Inc0.24-112.67%
CHRSCoherus Biosciences Inc0.85-144.79%
FBIOFortress Biotech Inc0.95-150.09%
ORMPOramed Pharmaceuticals Inc1.50-179.34%
AGENAgenus Inc3.01-258.86%
INVAInnoviva Inc3.15-266.48%
VXRTVaxart Inc3.55-287.37%
CRMDCorMedix Inc3.63-291.52%
CVACCureVac N.V.4.45-334.66%
GLPGGalapagos NV4.86-356.47%
SRPTSarepta Therapeutics Inc4.88-357.69%
ABEOAbeona Therapeutics Inc5.39-384.37%
ABUSArbutus Biopharma Corp5.60-395.35%
ZVRAZevra Therapeutics Inc5.89-410.75%
SPROSpero Therapeutics Inc6.23-428.76%
CGENCompugen Ltd6.31-433.27%
RIGLRigel Pharmaceuticals6.87-462.73%
SLXNSilexion Therapeutics Corp7.30-485.11%
OMEROmeros Corporation9.26-588.70%
AUPHAurinia Pharmaceuticals Inc9.58-605.92%
PLXProtalix BioTherapeutics Inc10.89-674.86%
ACADAcadia Pharmaceuticals Inc11.73-719.07%
TBPHTheravance Biopharma Inc12.26-747.23%
ADMAAdma Biologics Inc12.42-755.47%
HRMYHarmony Biosciences Holdings Inc13.82-829.47%
SABSSAB Biotherapeutics Inc14.14-846.15%
NAGENiagen Bioscience Inc14.82-882.15%
INCYIncyte Corp15.82-935.16%
REGNRegeneron Pharmaceuticals Inc15.86-936.96%
PBYIPuma Biotechnology Inc17.32-1013.98%
CPRXCatalyst Pharmaceuticals Inc17.44-1020.50%
EXELExelixis Inc17.54-1025.71%
TGTXTG Therapeutics Inc18.97-1101.09%
MDXGMimedx Group Inc20.55-1184.83%
XOMAXOMA Royalty Corp22.87-1307.43%
ARGXArgen X SE24.30-1382.56%
CTMXCytomX Therapeutics Inc24.82-1410.17%
XOMAOXOMA Royalty Corp25.34-1437.81%
HALOHalozyme Therapeutics Inc25.62-1452.54%
XOMAPXOMA Royalty Corp25.67-1454.99%
VRTXVertex Pharmaceuticals Inc27.99-1577.69%
RPRXRoyalty Pharma plc - Class A28.69-1614.26%
SLNOSoleno Therapeutics Inc29.02-1631.56%
ASNDAscendis Pharma A/S30.09-1688.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2101.17%
APLSApellis Pharmaceuticals Inc39.02-2159.72%
BMRNBiomarin Pharmaceutical Inc42.21-2328.13%
KRYSKrystal Biotech Inc45.34-2493.44%
ONCBeiGene Ltd69.54-3770.66%
PHARPharming Group N.V.75.03-4060.19%
TECHBio-Techne Corp101.96-5481.83%
VCELVericel Corp109.92-5902.15%
ALNYAlnylam Pharmaceuticals Inc117.96-6326.74%
GMABGenmab140.29-7505.19%
TLXTelix Pharmaceuticals Ltd162.15-8659.17%
CORTCorcept Therapeutics Inc212.86-11335.60%